|
⚲
|
| Keyboard |
| Beyer Russell P
✚
|
|
|---|---|
| CIK # | 0001889754 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001889754] | |
| 4 | [0001889754] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SAB Biotherapeutics Inc | |
| Beyer Russell P |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2023-03-14 | Grant | 275,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2022-09-13 | Grant | 274,875 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2022-03-16 | Grant | 6,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2021-11-17 | Grant | 110,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2021-10-26 | Sell | 278 | $7.90 | 2,196 |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2021-10-25 | Grant | 129 | $7.78 | 1,004 |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2021-10-18 | Grant | 2,475 | $10.10 | 24,998 |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2021-09-29 | Grant | 10 | $10.08 | 101 |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2021-09-28 | Grant | 5 | $10.07 | 50 |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2021-09-28 | Grant | 149 | $10.08 | 1,502 |